Safe and Green Development Corporation Reports First Quarter 2024 Financial Results and Provides a Business Update
MIAMI, May 15, 2024 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD) (“SG Devco” or the “Company”) today […]
Oatly Group AB Announces Results of 2024 Annual General Meeting
MALMÖ, Sweden, May 15, 2024 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY) (“Oatly” or the “Company”), the world’s original […]
ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update
Key Highlights: Second research site selected to enhance enrollment in the Phase 2a clinical trial for Cholesterol Efflux MediatorTM VAR […]
TSX News -
TerraVest Industries Inc. Announces Closing of Upsized Bought Deal Offering of Common Shares and Concurrent Closing of the Over-Allotment Option
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 15, 2024 (GLOBE NEWSWIRE) […]
Kartoon Studios Continues Execution of Growth Strategy With Profitability Targeted for Q2 2025; Provides Business Update for the First Quarter of 2024
Kartoon Channel!’s Streaming Business Achieved Profitability in the First Quarter of 2024 and Continues Growth; User Rankings in Apple App […]
Airship AI Reports First Quarter 2024 Financial Results
Strong First Quarter 2024 Net Revenues of $10.6 Million Support Fiscal Year 2024 Triple-Digit Revenue Growth & Positive Cash Flow […]
The Real Good Food Company to Participate in the 24th Annual B. Riley Institutional Investor Conference
CHERRY HILL, N.J., May 15, 2024 (GLOBE NEWSWIRE) — The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” […]
Yield10 Bioscience Announces Delisting from Nasdaq
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, […]
Genasys Receives $2.7 Million U.S. Navy Order for LRAD Maritime Systems
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, today announced […]
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the […]
